TrialAIDS and behavior2024

Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial.

Stanley E Cooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.